Management of Refractory Skin Disease in Patients with Lupus Erythematosus
September 2005
in “
Best Practice & Research Clinical Rheumatology
”
corticosteroids retinoids antimalarials sulfasalazine auranofin thalidomide phenytoin azathioprine methotrexate mycophenolate mofetil biologic agents cytokine therapy sunscreens protective clothing topical corticosteroids intralesional corticosteroids steroids biologics topical steroids intralesional steroids
Studysummary This review discusses therapies for skin lesions in lupus erythematosus and reports no new clinical results, focusing on defining and managing refractory disease.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on sciencedirect.com →